Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ACHN

Achillion Pharmaceuticals (ACHN) Stock Price, News & Analysis

Achillion Pharmaceuticals logo

About Achillion Pharmaceuticals Stock (NASDAQ:ACHN)

Advanced Chart

Key Stats

Today's Range
$6.76
$6.76
50-Day Range
$6.76
$6.76
52-Week Range
$2.06
$7.01
Volume
N/A
Average Volume
8.44 million shs
Market Capitalization
$946.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ACHN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Achillion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ACHN Stock News Headlines

Kim P. Kamdar's Net Worth
Lexicon Pharmaceuticals (NASDAQ: LXRX)
Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
ACHN_old Historical Data
See More Headlines

ACHN Stock Analysis - Frequently Asked Questions

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced its earnings results on Thursday, November, 7th. The biopharmaceutical company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.02.

Based on aggregate information from My MarketBeat watchlists, some other companies that Achillion Pharmaceuticals investors own include Chesapeake Energy (CHKAQ), Skyworks Solutions (SWKS), Madrigal Pharmaceuticals (MDGL), Noble (NEBLQ), Gilead Sciences (GILD), Eiger BioPharmaceuticals (EIGR) and Meta Platforms (META).

Company Calendar

Last Earnings
11/07/2019
Today
7/26/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ACHN
CIK
1070336
Fax
N/A
Employees
56
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.51)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$70.27 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-30.95%
Return on Assets
-29.09%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
8.96
Quick Ratio
8.96

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.92 per share
Price / Book
3.52

Miscellaneous

Outstanding Shares
140,047,000
Free Float
N/A
Market Cap
$946.72 million
Optionable
Optionable
Beta
1.59
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:ACHN) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners